Chronic Lower Back Pain Market to Reach US$ 9,770.1 Million by 2033 | IMARC Group

The newly published report by IMARC Group, titled "Chronic Lower Back Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the chronic lower back pain market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.

How big is the chronic lower back pain market?

According to IMARC Group, in 2022, the total value of the seven major markets (7MM) for chronic lower back pain market amounted to US$ 6,449.9 Million. Looking forward, these markets are anticipated to reach US$ US$ 9,770.1 Million by 2033, at a growth rate (CAGR) of 3.85% from 2023-2033.

What is Chronic lower back pain?
Chronic lower back pain refers to a debilitating condition marked by continuous pain in the lower back that persists for more than 12 weeks, even after attempts to treat or manage it. The feeling of pain can be sharp, achy, or dull and is usually accompanied by tenderness, muscle spasms, and stiffness. If the disease progresses, it can limit muscle mobility and create difficulty in performing daily tasks, such as bending, lifting, sitting for long periods, etc. The diagnosis of this condition involves a thorough medical evaluation, blood tests, and various imaging tests, including CT scans, X-rays, MRI scans, etc.

Request a Free Sample Report: https://www.imarcgroup.com/chronic-lower-back-pain-market/requestsample

The growing instances of muscle or ligament strain caused by heavy lifting, poor posture, sudden movements, etc., are primarily driving the chronic lower back pain market. Besides this, the increasing cases of various associated risk factors, including herniated discs, spinal stenosis, osteoporosis, degenerative disc diseases, sciatica, etc., are also bolstering the market growth. Moreover, the escalating application of massage therapies, such as trigger point therapy and deep tissue massage, to help minimize muscle tension and facilitate relaxation is acting as another significant growth-inducing factor.

Additionally, the rising adoption of radiofrequency ablation, which utilizes heat to destroy nerve fibers that transmit pain signals from the lower back to the brain, for treating the condition is creating a positive outlook for the market. Besides this, numerous pharmaceutical companies are increasingly investing in research activities to develop analgesics or painkillers that are more effective, affordable, and easier to administer, which in turn is anticipated to drive the chronic lower back pain market in the coming years.

Report Period:

Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033

Countries Included:

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the chronic lower back pain market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the chronic lower back pain market
Reimbursement scenario in the market
In-market and pipeline drugs

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Regulatory Status

Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/request?type=report&id=7232&flag=C

Key Questions Answered in this Report:

How has the chronic lower back pain market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the chronic lower back pain market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the chronic lower back pain market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?

Browse the Latest Research Report:

Urothelial Carcinoma Market Report: https://www.imarcgroup.com/urothelial-carcinoma-market

Erythema Market Report: https://www.imarcgroup.com/erythema-market

Hypothyroidism Market Report: https://www.imarcgroup.com/hypothyroidism-market

Von Willebrand Disease Market Report: https://www.imarcgroup.com/von-willebrand-disease-market

How This Report Can Help You:

The report on chronic lower back pain market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the chronic lower back pain market.
The chronic lower back pain market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.
Our report on the chronic lower back pain market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.

Contact US

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us: -

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.